Wygant Jonathan sold $1.1M of VCYT
Wygant Jonathan (VP, Chief Accounting Officer) sold 24,000 shares of VERACYTE, INC. (VCYT) at $45.40 ($1.09M total) on 2026-05-22.
How this was made
The 30-second read
Why it matters
Insider selling disclosures can create short-lived sentiment pressure, but without earnings, guidance, or business developments, the trading signal is usually weak.
Market read
VCYT-specific insider selling of ~$1.09M is disclosed; absent other catalysts, expected impact is limited to sentiment.
What to watch
No 10b5-1 plan is cited, but the article also lacks details on tax, diversification needs, or whether other insiders/funds changed positions around the same time.
Background
The article is a SEC Form 4 insider transaction disclosure for Veracyte, Inc. (VCYT).
Ticker impact
Veracyte CFO Jonathan Wygant filed an open-market sale of 24,000 shares for about $1.09M on 2026-05-22.
Low probability of a sustained move; any reaction is likely brief unless accompanied by other news.
Form 4 insider sales are common and the filing notes no pre-arranged 10b5-1 plan, but the article provides no earnings/guidance or operational catalyst.
Market effects
Minimal; this is company-specific insider activity without sector-wide read-across in the article.
None indicated.
None indicated.
Counterpoint
The sale may be routine liquidity/portfolio rebalancing rather than a negative signal, especially given the absence of any accompanying negative company event in the filing.
Key entities
- issuerVERACYTE, INC.
Subject of the Form 4 insider sale by CFO Jonathan Wygant.
- insiderJonathan Wygant
VP, Chief Accounting Officer who sold 24,000 shares in an open-market transaction.
